Sofinnova Investments’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Sofinnova Investments’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-481,270	Closed	-$46.7M	–	81
2019 Q3	$46.7M	Hold	481,270	–	–	4.22%	6
2019 Q2	$49.3M	Hold	481,270	–	–	4.53%	6
2019 Q1	$54.8M	Hold	481,270	–	–	5.28%	7
2018 Q4	$18.8M	Hold	481,270	–	–	2.35%	13
2018 Q3	$26.3M	Hold	481,270	–	–	2.34%	11
2018 Q2	$39.8M	Hold	481,270	–	–	4.51%	7
2018 Q1	$32M	Buy	+481,270	New	+$27.8M	5.51%	6

Sofinnova Investments's ONCE Position: Q4 2019 in Review

Sofinnova Investments sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 481,270 shares — an estimated $46.7M sold.

Sofinnova Investments first reported a position in ONCE in Q1 2018 and held it in 7 quarters. The position peaked at $54.8M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Sofinnova Investments reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Sofinnova Investments sold 481,270 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $46.7M.
Sofinnova Investments first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
Sofinnova Investments's Spark Therapeutics, Inc. Common Stock position peaked at $54.8M in Q1 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Sofinnova Investments's 13F filing for Q4 2019, filed 14 Feb 2020.